Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Haurum

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of Experimental Medicine|August 3, 1999
Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivoJ S Haurum, I B Høier, G Arsequell, et al.
Tissue Antigens|October 6, 2000
Lectin purified human class I MHC-derived peptides: evidence for presentation of glycopeptides in vivoI B Kastrup, S Stevanovic, G Arsequell, et al.
The Journal of Experimental Medicine|August 1, 1994
Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytesJ S Haurum, G Arsequell, A C Lellouch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1999
Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTLM H Andersen, J E Bonfill, A Neisig, et al.
European Journal of Immunology|December 1, 1995
Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognitionJ S Haurum, L Tan, G Arsequell, et al.
The Journal of Experimental Medicine|June 1, 1995
Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raisedA B Hill, S P Lee, J S Haurum, et al.
Immunity|February 19, 1999
Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivityA Glithero, J Tormo, J S Haurum, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Experimental Medicine|August 3, 1999
Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivoJ S Haurum, I B Høier, G Arsequell, et al.
Tissue Antigens|October 6, 2000
Lectin purified human class I MHC-derived peptides: evidence for presentation of glycopeptides in vivoI B Kastrup, S Stevanovic, G Arsequell, et al.
The Journal of Experimental Medicine|August 1, 1994
Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytesJ S Haurum, G Arsequell, A C Lellouch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1999
Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTLM H Andersen, J E Bonfill, A Neisig, et al.
European Journal of Immunology|December 1, 1995
Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognitionJ S Haurum, L Tan, G Arsequell, et al.
The Journal of Experimental Medicine|June 1, 1995
Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raisedA B Hill, S P Lee, J S Haurum, et al.
Immunity|February 19, 1999
Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivityA Glithero, J Tormo, J S Haurum, et al.
Pageof 2